United States (US) Age-Related Macular Degeneration Market (2025-2031) | Trends, Forecast, Outlook, Companies, Segmentation, Value, Share, Growth, Competitive Landscape, Size & Revenue, Analysis, Industry

Name: United States (US) Age-Related Macular Degeneration Market (2025-2031) | Trends & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Product (Eylea, Lucentis, Beovu, Others), By Disease Type (Dry AMD, Wet AMD), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) And Competitive Landscape

Product Code: ETC9958769	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Age-Related Macular Degeneration Market Outlook
Market Size of United States (US) Age-Related Macular Degeneration Market, 2024
Forecast of United States (US) Age-Related Macular Degeneration Market, 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Revenues & Volume for the Period 2021- 2031
United States (US) Age-Related Macular Degeneration Market Trend Evolution
United States (US) Age-Related Macular Degeneration Market Drivers and Challenges
United States (US) Age-Related Macular Degeneration Price Trends
United States (US) Age-Related Macular Degeneration Porter's Five Forces
United States (US) Age-Related Macular Degeneration Industry Life Cycle
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
United States (US) Age-Related Macular Degeneration Import Export Trade Statistics
Market Opportunity Assessment By Product
Market Opportunity Assessment By Disease Type
Market Opportunity Assessment By Distribution Channel
United States (US) Age-Related Macular Degeneration Top Companies Market Share
United States (US) Age-Related Macular Degeneration Competitive Benchmarking By Technical and Operational Parameters
United States (US) Age-Related Macular Degeneration Company Profiles
United States (US) Age-Related Macular Degeneration Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Age-Related Macular Degeneration Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Age-Related Macular Degeneration Market - Industry Life Cycle

3.4 United States (US) Age-Related Macular Degeneration Market - Porter's Five Forces

3.5 United States (US) Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.7 United States (US) Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Age-Related Macular Degeneration Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in the United States

4.2.2 Technological advancements in treatment options for age-related macular degeneration

4.2.3 Growing awareness about eye health and early detection of age-related macular degeneration

4.3 Market Restraints

4.3.1 High cost of advanced treatments and therapies

4.3.2 Limited access to specialized healthcare services in certain regions

4.3.3 Regulatory challenges and approval processes for new treatments

5 United States (US) Age-Related Macular Degeneration Market Trends

6 United States (US) Age-Related Macular Degeneration Market, By Types

6.1 United States (US) Age-Related Macular Degeneration Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Eylea, 2021- 2031F

6.1.4 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Lucentis, 2021- 2031F

6.1.5 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Beovu, 2021- 2031F

6.1.6 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Age-Related Macular Degeneration Market, By Disease Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Dry AMD, 2021- 2031F

6.2.3 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Wet AMD, 2021- 2031F

6.3 United States (US) Age-Related Macular Degeneration Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.3.3 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F

6.3.4 United States (US) Age-Related Macular Degeneration Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 United States (US) Age-Related Macular Degeneration Market Import-Export Trade Statistics

7.1 United States (US) Age-Related Macular Degeneration Market Export to Major Countries

7.2 United States (US) Age-Related Macular Degeneration Market Imports from Major Countries

8 United States (US) Age-Related Macular Degeneration Market Key Performance Indicators

8.1 Average age of diagnosis for age-related macular degeneration patients

8.2 Number of clinical trials for age-related macular degeneration treatments in the US

8.3 Percentage of the population receiving regular eye exams for early detection of age-related macular degeneration

9 United States (US) Age-Related Macular Degeneration Market - Opportunity Assessment

9.1 United States (US) Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.3 United States (US) Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Age-Related Macular Degeneration Market - Competitive Landscape

10.1 United States (US) Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024

10.2 United States (US) Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Middle East Age-Related Macular Degeneration Market

North America Age-Related Macular Degeneration Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here